This service offering is compliant with applicable federal and state regulations including HIPAA which govern the privacy and security of human subjects research.
Real-time Clinical Trial Bio-metric Platform
GluCONIX™ encompasses our turn-key customized design, development, proprietary mobile devices,
intelligent systems and wireless data service provider capabilities available to the
pharmaceutical and medical device industry specifically addressing the diabetic condition.
healthcordia's GluCONIX is a true one-stop-shop for everything you need for your research
including wireless airtime, patient records management and end-to-end command and remote control.
Accelerating new drug discoveries and advancing diagnostic devices requires simplicity and accuracy,
not to mention timely feedback. We think of it as having a 'window on the patient'.

Our real-time Virtual-Loop™ technology encompasses certified mobile devices,
wireless data collection, protocol specific messaging logic, alerts, reminders, requests for data, analysis and reporting.
Nobody else thinks the way we do about patient data and real-time usage scenarios.
With our patent pending BioTimeSync™ feature, the internal clocks of medical
devices like glucose meters are constantly synchronized to the Atomic Clock.
healthcordia ensures that your data is beyond question with accuracy not possible using any other approach.
GluCONIX Wireless Trial Platform Announcement
The Fast Fail Strategy
Read more about
how real-time wireless technology accelerates the clinical trials industry.

No more waiting for tabulated reports or wading through mountains of paper to find
out that you need to enroll a replacement trial participant.
This notion of fast fail extends beyond patients to fast-failing
a trial in its entirety should the data not support the required outcomes.
Fast Fail with GluCONIX could mean significant cost savings for your programs
by shortening your lifecycle in the search of cures, better therapies and improved diagnostics.
Clinical Trials
Pharma Trials
- Alternative Delivery Strategies for Insulin Glargine in the Care and Treatment of At Risk Children with Type 1 Diabetes (Open)
- Inhaled Insulin Surveillance Protocol (Under Development)
So advanced, it's simple.